Physician profile
Aaron D Smith
NPI 1417159625
$1,457.53
in general payments reported to CMS, 2019-2025
10 companies · $164 in 2025
The $164 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $329 · 2020: $328 · 2021: $103 · 2022: $335 · 2023: $199 · 2025: $164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $363.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $362.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sientra, INC. | $577.01 | 2019-2022 | |
| Mentor Worldwide LLC | $258.98 | 2020-2022 | |
| Allergan, INC. | $179.21 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $151.03 | 2021-2025 | |
| Acera Surgical, INC. | $134.88 | 2023 | Restrata Wound Matrix |
| Integra Lifesciences Corporation | $64.00 | 2023 | Durasorb Monofilament Mesh |
| Motiva USA, LLC | $27.45 | 2025 | |
| Merz North America, INC. | $23.45 | 2019 | |
| Baxter Healthcare | $22.58 | 2021 | |
| Stryker Corporation | $18.94 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.